Jazz Pharmaceuticals JAZZ Other — Revenue from Contract with Customer, Excluding Assessed Tax

Other product segments

Similar metrics at other companies

ETROther revenues — Revenue from Contract with Customer, Excluding Assessed Tax

$36.28M-41.5%

NTRSOther — Revenue from Contract with Customer, Excluding Assessed Tax

$68.6M+8.2%

SIGOther — Revenue from Contract with Customer, Excluding Assessed Tax

$29.5M-25.1%

MSGEOther — Revenue from Contract with Customer, Excluding Assessed Tax

$1.22M+40.0%

KMXOther — Revenue from Contract with Customer, Excluding Assessed Tax

$4.7M+38.2%

VRAOther — Revenue from Contract with Customer, Excluding Assessed Tax

$2.39M+13.4%

FAQ

What is Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax?

Jazz Pharmaceuticals (JAZZ) reported other — revenue from contract with customer, excluding assessed tax of $2.7M in Q1 2026.

How has Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax changed year-over-year?

Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax decreased by 73.8% year-over-year, from $10.3M to $2.7M.

What is the long-term trend for Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax?

Over 4 years (2021 to 2025), Jazz Pharmaceuticals's other — revenue from contract with customer, excluding assessed tax has grown at a 19.8% compound annual growth rate (CAGR), from $9.8M to $20.16M.

What does other — revenue from contract with customer, excluding assessed tax mean?

This metric captures the net revenue generated from the sale of products or services categorized within the 'Other' segment, excluding any sales-based taxes. It represents the top-line contribution from secondary product lines that do not fall under the company's primary therapeutic franchises. Tracking this revenue stream provides insight into the diversification of the product portfolio and the growth trajectory of non-core or emerging assets.